| Fri, 05 Jun 2020 15:06:43: | Left out of Warp Speed, Novavax scores $60M defense contract for COVID-19 shot
|
| Fri, 05 Jun 2020 14:05:46: | After Operation Warp Speed picks 5 finalists, experts question why some vaccines were left out
|
| Fri, 05 Jun 2020 13:26:30: | Inovio accuses manufacturing partner of hampering COVID-19 vaccine scale-up in lawsuit
|
| Fri, 05 Jun 2020 13:20:55: | Lonza poaches Roche exec for CEO as Moderna COVID-19 collab speeds ahead
|
| Fri, 05 Jun 2020 10:28:02: | FiercePharmaAsia—'Onshoring' drug manufacturing; Takeda's IBD pipeline cull; Legend's $350M IPO
|
| Thu, 04 Jun 2020 19:57:40: | What does it mean to #BeFierce? Our new look tells the story
|
| Thu, 04 Jun 2020 15:35:16: | AstraZeneca unveils massive $750M deal in effort to produce billions of COVID-19 shots
|
| Thu, 04 Jun 2020 15:21:25: | Gearing up for commercial ops, Moderna recruits Amgen vet Meline as CFO
|
| Thu, 04 Jun 2020 14:27:29: | Novartis' Cosentyx chases Lilly's just-approved Taltz with long-term data in spondyloarthritis
|
| Thu, 04 Jun 2020 13:52:31: | Remdesivir stockpiling could help push COVID-19 drug into profitable territory for Gilead: analyst
|
| Thu, 04 Jun 2020 13:29:32: | Europe mulls BARDA-style development contracts for COVID-19 vaccines: Bloomberg
|
| Wed, 03 Jun 2020 17:59:42: | Pfizer, Merck, AZ, J&J and Moderna selected as 'Warp Speed' finalists: NYT
|
| Wed, 03 Jun 2020 15:11:43: | Novavax enlists AGC Biologics to manufacture adjuvant for COVID-19 shot
|
| Wed, 03 Jun 2020 15:08:35: | Bristol Myers Squibb's Zeposia angles for lucrative ulcerative colitis nod with new data
|
| Wed, 03 Jun 2020 14:16:11: | FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab
|
| Wed, 03 Jun 2020 13:17:08: | Former Biogen employee arrested in Beijing after hiding her coronavirus symptoms
|
| Wed, 03 Jun 2020 12:54:20: | Are metformin recalls just the start? Valisure CEO calls for independent foreign drug tests amid COVID-19
|
| Tue, 02 Jun 2020 13:18:23: | Drugmakers struggle to meet demand for antidepressant Zoloft amid COVID-19
|
| Mon, 01 Jun 2020 21:48:28: | WuXi AppTec welcomes vet of Celgene's troubled cell therapy program to CAR-T leadership role
|
| Mon, 01 Jun 2020 19:57:11: | With protests continuing, Merck CEO Frazier urges businesses to help bridge the racial equity gap
|
| Mon, 01 Jun 2020 19:33:41: | Emergent BioSolutions, BARDA reach $628M deal to manufacture COVID-19 vaccine hopefuls
|
| Mon, 01 Jun 2020 17:12:25: | Bristol Myers Squibb's Zeposia launches into crowded MS market
|
| Sun, 31 May 2020 20:58:07: | ASCO: Has AstraZeneca finally found a place for long-plagued I-O candidate tremelimumab?
|
| Sun, 31 May 2020 18:03:59: | ASCO: Merck, Eisai pad case for liver cancer nod with Keytruda-Lenvima combo data
|
| Sat, 30 May 2020 18:37:30: | In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K.
|
